MedTrace Logo

Laparoscopic Surgical Treatment of Aorto-iliac Occlusive Disease

NCT01259908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-06-22

No results posted yet for this study

Summary

Patients with aorto-iliac occlusive disease (TASC, type D) operated with a totally laparoscopic aortobifemoral bypass operation and open aortobifemoral bypass operation will be followed up and the results will be compared between the two procedures on the basis of the primary endpoint, a composite endpoint defined as a combined incidence of systemic morbidity, graft thrombosis and all-cause mortality.

Conditions

  • Aorto Iliac Occlusive Disease

Interventions

PROCEDURE

Laparoscopic vs open Ygraft

Patients with aorto-iliac occlusive disease TASC type D operated with either laparoscopic aortobifemoral bypass or open aortobifemoral bypass shall be compared.

Sponsors & Collaborators

  • Sykehuset Ostfold

    collaborator OTHER

  • Sorlandet Hospital HF

    collaborator OTHER_GOV

  • Oslo University Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01259908 on ClinicalTrials.gov